515 related articles for article (PubMed ID: 15055300)
1. TP53 mutation spectra and load: a tool for generating hypotheses on the etiology of cancer.
Olivier M; Hussain SP; Caron de Fromentel C; Hainaut P; Harris CC
IARC Sci Publ; 2004; (157):247-70. PubMed ID: 15055300
[TBL] [Abstract][Full Text] [Related]
2. Tumor suppressor genes: at the crossroads of molecular carcinogenesis, molecular epidemiology and human risk assessment.
Hussain SP; Hofseth LJ; Harris CC
Lung Cancer; 2001 Dec; 34 Suppl 2():S7-15. PubMed ID: 11720736
[TBL] [Abstract][Full Text] [Related]
3. TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer.
Hussain SP; Schwank J; Staib F; Wang XW; Harris CC
Oncogene; 2007 Apr; 26(15):2166-76. PubMed ID: 17401425
[TBL] [Abstract][Full Text] [Related]
4. p53 mutation spectrum and load: the generation of hypotheses linking the exposure of endogenous or exogenous carcinogens to human cancer.
Hussain SP; Harris CC
Mutat Res; 1999 Jul; 428(1-2):23-32. PubMed ID: 10517975
[TBL] [Abstract][Full Text] [Related]
5. Chemical and physical carcinogenesis: advances and perspectives for the 1990s.
Harris CC
Cancer Res; 1991 Sep; 51(18 Suppl):5023s-5044s. PubMed ID: 1884379
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms in XPD and TP53 and mutation in human lung cancer.
Mechanic LE; Marrogi AJ; Welsh JA; Bowman ED; Khan MA; Enewold L; Zheng YL; Chanock S; Shields PG; Harris CC
Carcinogenesis; 2005 Mar; 26(3):597-604. PubMed ID: 15564288
[TBL] [Abstract][Full Text] [Related]
7. [TP53 mutations and molecular epidemiology].
Otsuka K; Ishioka C
Gan To Kagaku Ryoho; 2007 May; 34(5):683-9. PubMed ID: 17496437
[TBL] [Abstract][Full Text] [Related]
8. Mutagenesis of the H-ras protooncogene and the p53 tumor suppressor gene.
Cerutti P; Hussain P; Pourzand C; Aguilar F
Cancer Res; 1994 Apr; 54(7 Suppl):1934s-1938s. PubMed ID: 7907948
[TBL] [Abstract][Full Text] [Related]
9. p53 and lung cancer.
Brambilla E; Brambilla C
Pathol Biol (Paris); 1997 Dec; 45(10):852-63. PubMed ID: 9769949
[TBL] [Abstract][Full Text] [Related]
10. BRCA1 and TP53 mutation spectrum of breast carcinoma in an ethnic population of Kashmir, an emerging high-risk area.
Eachkoti R; Hussain I; Afroze D; Aejazaziz S; Jan M; Shah ZA; Das BC; Siddiqi MA
Cancer Lett; 2007 Apr; 248(2):308-20. PubMed ID: 16996204
[TBL] [Abstract][Full Text] [Related]
11. TP53 and liver carcinogenesis.
Staib F; Hussain SP; Hofseth LJ; Wang XW; Harris CC
Hum Mutat; 2003 Mar; 21(3):201-16. PubMed ID: 12619106
[TBL] [Abstract][Full Text] [Related]
12. TP53 mutations in workers exposed to occupational carcinogens.
Vähäkangas K
Hum Mutat; 2003 Mar; 21(3):240-51. PubMed ID: 12619109
[TBL] [Abstract][Full Text] [Related]
13. p53 website and analysis of p53 gene mutations in human cancer: forging a link between epidemiology and carcinogenesis.
Soussi T; Dehouche K; Béroud C
Hum Mutat; 2000; 15(1):105-13. PubMed ID: 10612830
[TBL] [Abstract][Full Text] [Related]
14. Mutability of p53 hotspot codons to benzo(a)pyrene diol epoxide (BPDE) and the frequency of p53 mutations in nontumorous human lung.
Hussain SP; Amstad P; Raja K; Sawyer M; Hofseth L; Shields PG; Hewer A; Phillips DH; Ryberg D; Haugen A; Harris CC
Cancer Res; 2001 Sep; 61(17):6350-5. PubMed ID: 11522624
[TBL] [Abstract][Full Text] [Related]
15. The TP53 gene, tobacco exposure, and lung cancer.
Toyooka S; Tsuda T; Gazdar AF
Hum Mutat; 2003 Mar; 21(3):229-39. PubMed ID: 12619108
[TBL] [Abstract][Full Text] [Related]
16. TP53 and KRAS mutation load and types in lung cancers in relation to tobacco smoke: distinct patterns in never, former, and current smokers.
Le Calvez F; Mukeria A; Hunt JD; Kelm O; Hung RJ; Tanière P; Brennan P; Boffetta P; Zaridze DG; Hainaut P
Cancer Res; 2005 Jun; 65(12):5076-83. PubMed ID: 15958551
[TBL] [Abstract][Full Text] [Related]
17. Molecular epidemiology and carcinogenesis: endogenous and exogenous carcinogens.
Hussain SP; Harris CC
Mutat Res; 2000 Apr; 462(2-3):311-22. PubMed ID: 10767641
[TBL] [Abstract][Full Text] [Related]
18. Comparison of induced and cancer-associated mutational spectra using multivariate data analysis.
Lewis PD; Manshian B; Routledge MN; Scott GB; Burns PA
Carcinogenesis; 2008 Apr; 29(4):772-8. PubMed ID: 18296683
[TBL] [Abstract][Full Text] [Related]
19. p53 as a sensor of carcinogenic exposures: mechanisms of p53 protein induction and lessons from p53 gene mutations.
Hainaut P; Vähäkangas K
Pathol Biol (Paris); 1997 Dec; 45(10):833-44. PubMed ID: 9769947
[TBL] [Abstract][Full Text] [Related]
20. TP53 tumour suppressor gene: clues to molecular carcinogenesis and cancer therapy.
Wang XW; Harris CC
Cancer Surv; 1996; 28():169-96. PubMed ID: 8977035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
